GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.05 $16.17 Friday, 19th Apr 2024 DCPH stock ended at $14.67. This is 3.09% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.56% from a day low at $14.05 to a day high of $14.69.
90 days $13.50 $17.73
52 weeks $9.90 $17.73

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
2024-04-19 $14.17 $14.69 $14.05 $14.67 373 106
2024-04-18 $14.67 $14.91 $14.19 $14.23 743 106
2024-04-17 $14.97 $15.00 $14.66 $14.72 278 082
2024-04-16 $14.76 $15.00 $14.65 $14.84 236 227
2024-04-15 $15.07 $15.13 $14.52 $14.90 489 968
2024-04-12 $15.46 $15.51 $14.87 $15.05 283 514
2024-04-11 $15.81 $15.81 $15.24 $15.52 227 957
2024-04-10 $15.11 $15.71 $14.89 $15.61 518 424
2024-04-09 $14.94 $15.69 $14.94 $15.64 352 737
2024-04-08 $15.42 $15.56 $14.71 $15.01 219 665
2024-04-05 $15.03 $15.57 $14.93 $15.34 296 087
2024-04-04 $15.24 $15.61 $15.09 $15.14 356 562
2024-04-03 $15.08 $15.39 $15.01 $15.29 412 133
2024-04-02 $15.49 $15.64 $14.99 $15.19 384 774
2024-04-01 $15.62 $16.02 $15.43 $15.76 811 230
2024-03-28 $15.37 $16.17 $15.25 $15.73 763 901
2024-03-27 $15.03 $15.20 $14.74 $15.18 288 073
2024-03-26 $15.46 $15.50 $14.79 $14.82 280 999
2024-03-25 $15.34 $15.61 $15.25 $15.30 296 946
2024-03-22 $15.55 $15.63 $15.23 $15.23 236 670
2024-03-21 $15.82 $16.09 $15.48 $15.50 310 908
2024-03-20 $15.00 $15.84 $15.00 $15.75 492 082
2024-03-19 $14.92 $15.48 $14.86 $14.97 713 159
2024-03-18 $15.55 $15.72 $14.65 $14.85 594 348
2024-03-15 $15.83 $16.49 $15.55 $15.59 1 326 788
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT